Edward C English's Net Worth
$5.76 Million
Who is Edward C English?
Edward C English has an estimated net worth of $5.76 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., Xilio Therapeutics, Inc., AMAG PHARMACEUTICALS INC., and PRAECIS PHARMACEUTICALS INC.
SEC CIK
Edward C English's CIK is 0001302600
Past Insider Trading and Trends
2016 was Edward C English's most active year for acquiring shares with 10 total transactions. Edward C English's most active month to acquire stocks was the month of February. 2016 was Edward C English's most active year for disposing of shares, totalling 17 transactions. Edward C English's most active month to dispose stocks was the month of May. 2017 saw Edward C English paying a total of $945,883.16 for 33,887 shares, this is the most they've acquired in one year. In 2017 Edward C English cashed out on 59,578 shares for a total of $4,465,250.71, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TESARO, Inc. No price found
VP Finance & Administration
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$86.67 | -$1,048,165.04 | 396 |
Scheduled
|
Sep 6
| ||
Form 4
|
—
|
0
|
$83.39 | -$939,529.82 | 396 |
Scheduled
|
Jun 6
| ||
Form 4
|
—
|
0
|
$103.51 | -$1,491,000.00 | 396 |
Scheduled
|
Mar 6
| ||
Form 4
|
∞
| 396 |
$177.61 | -$40,672.69 | 396 |
Scheduled
|
Mar 1 - Mar 2
| ||
Form 4
|
—
|
0
|
$79.22 | -$996,670.00 |
0
|
Scheduled
|
Dec 12
| ||
Form 4
|
—
|
0
|
$56.04 | -$455,128.00 |
0
|
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$32.14 | -$120,599.00 |
0
|
Scheduled
|
Jun 10
| ||
Form 4
|
—
|
0
|
$33.62 | -$141,270.00 |
0
|
Scheduled
|
Mar 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
$34.88 | -$520,576.50 |
0
|
Scheduled
|
Dec 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844
PRINCIPAL ACCOUNTING OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMAG PHARMACEUTICALS INC. No price found
VP, Controller, Interim CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PRAECIS PHARMACEUTICALS INC No price found
VP, CFO, Treasurer & Ass. Sec.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.96K |
$5.00 | -$9,780.00 |
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||